ACE2 and COVID-19: The expression of Angiotensin-Converting Enzyme 2 (ACE-2) in both exocrine and endocrine pancreatic glands renders the pancreas a potential target for the virus [8], ACE-2 being the entry point for the SARS-Cov-2 initiating the COVID-19 pathogenesis [10,11] Though the pancreatic injury likely involves both a direct and an inflammatory-mediated process.